MAPT and supranuclear palsy, progressive, 1: Although the predominant tau isoform in all PSP lesions has four microtubule-binding domains (4R), the four distinct tau lesions have morphological and/or biochemical differences [17, 54], indicative of possible cell-specific pathomechanisms.